MedTrace Logo

Occluder Size Determination in Transcatheter ASD II Closure Based on 3D TEE Assessment

NCT02601768 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2015-11-10

No results posted yet for this study

Summary

The aim of this study is to determine whether three-dimensional tranesophageal echocardiography (3D TEE) assessment of ostium secundum atrial septal defect (ASD II) may be as efficient as two-dimensional (2D) TEE assessment complemented by the balloon-sizing during transcatheter closure of the defect.

Conditions

  • Ostium Secundum Atrial Septal Defect

Interventions

DEVICE

Transcatheter closure of ASD II

Transcatheter closure of ASD II performed in our center.

Sponsors & Collaborators

  • National Institute of Cardiology, Warsaw, Poland

    lead OTHER

Principal Investigators

  • Jan Henzel, MD · Institute Of Cardiology in Warsaw

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2016-06-30
Completion
2016-12-31

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02601768 on ClinicalTrials.gov